Oct 5 (Reuters) – Polyrizon Ltd: * POLYRIZON FILES FOR U.S. PATENT APPLICATION TO EXPAND IP MOAT AROUND INTRANASAL DRUG-DELIVERY PLATFORM Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)